Finance

Lists
VEEV:NYSE
Veeva Systems Inc
USD 282,50
-0,35%
(-1,00) 1D
USD 282,50
0,00% (0,00)
After hours
Closed: 7 Okt., 16:01:35 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VEEV...
Open
USD 284,23
High
USD 286,98
Low
USD 279,80
Mkt. cap
45,74 mjd
Avg. vol.
1,76 m
Volume
1,12 m
P/E ratio
46,20
52-wk high
USD 308,36
52-wk low
USD 148,05
EPS
USD 6,11
Beta
0,93
Shares outstanding
161,91 m
No. of employees
8 k
Open
USD 284,23
High
USD 286,98
Low
USD 279,80
Mkt. cap
45,74 mjd
Avg. vol.
1,76 m
Volume
1,12 m
P/E ratio
46,20
52-wk high
USD 308,36
52-wk low
USD 148,05
EPS
USD 6,11
Beta
0,93
Shares outstanding
161,91 m
No. of employees
8 k
News stories
From web sources and news partners
Profile
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing. The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Wikipedia
About Veeva Systems Inc
CEOPeter Gassner
Employees7,93 k
Founded2007
HeadquartersPleasanton, Kalifornië, Verenigde State van Amerika
SectorHealth care
Websiteveeva.com
Analyst ratings
Based on 24 analysts giving stock ratings to VEEV in the past 3 months
Buy
Buy
17
Hold
6
Sell
1
12-month forecast
Based on 24 Wall Street analysts offering 12 month price targets for VEEV in the last 3 months.
Highest
Current USD 282,50
USD 340,00 (+20,35%)
Average
USD 293,57 (+3,92%)
Lowest
USD 180,00 (-36,28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stan Berenshteyn
Wells Fargo
Buy
Maintained
USD 330,00
+16,8%
09/30/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
USD 275,00
-2,7%
09/18/2026
Unknown Analyst
CFRA
Buy
Upgraded
-
-
09/16/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
USD 283,00
+0,2%
09/15/2026
Alexei Gogolev
J.P. Morgan
Buy
Maintained
USD 299,00
+5,8%
09/01/2026
Tyler Radke
Citi
Hold
Maintained
USD 273,00
-3,4%
08/28/2026
Brian Peterson
Raymond James
Buy
Maintained
USD 330,00
+16,8%
08/27/2026
Kenneth Wong
Oppenheimer
Buy
Reiterated
USD 325,00
+15%
08/27/2026
Gabriela Borges
Goldman Sachs
Sell
Maintained
USD 180,00
-36,3%
08/26/2026
Kirk Materne
Evercore ISI
Hold
Maintained
USD 250,00
-11,5%
08/27/2026
Rishi Jaluria
RBC Capital
Buy
Maintained
USD 325,00
+15%
08/26/2026
Sean Dodge
BMO Capital
Hold
Reiterated
USD 270,00
-4,4%
08/27/2026
David Larsen
BTIG
Buy
Maintained
USD 340,00
+20,4%
08/26/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
USD 280,00
-0,9%
08/27/2026
Karl Keirstead
UBS
Hold
Reiterated
USD 290,00
+2,7%
08/28/2026
Ryan MacDonald
Needham
Buy
Reiterated
USD 310,00
+9,7%
08/27/2026
David Hynes
Canaccord Genuity
Hold
Maintained
USD 260,00
-8%
08/27/2026
Tamjid Chowdhury
Guggenheim
Buy
Maintained
USD 310,00
+9,7%
08/27/2026
David Grossman
Stifel Nicolaus
Buy
Maintained
USD 300,00
+6,2%
08/27/2026
Joseph Vruwink
Robert W. Baird
Buy
Maintained
USD 300,00
+6,2%
08/27/2026
Billy Fitzsimmons
Piper Sandler
Buy
Maintained
USD 320,00
+13,3%
08/27/2026
Dylan Becker
William Blair
Buy
Maintained
-
-
08/27/2026
Jailendra Singh
Truist Financial
Buy
Maintained
-
-
08/26/2026
Saket Kalia
Barclays
Buy
Maintained
USD 315,00
+11,5%
08/27/2026
John Difucci
Guggenheim
Buy
Initiated
USD 232,00
-17,9%
07/22/2026
Unknown Analyst
Guggenheim
Buy
Initiated
USD 232,00
-17,9%
07/22/2026
Martin Yang
Oppenheimer
Buy
Reiterated
USD 225,00
-20,4%
06/04/2026
Hannah Rudoff
Piper Sandler
Buy
Maintained
USD 235,00
-16,8%
06/04/2026
Adam Hotchkiss
Goldman Sachs
Sell
Maintained
USD 165,00
-41,6%
06/04/2026
Unknown Analyst
Stephens
Buy
Maintained
USD 324,00
+14,7%
03/05/2026
Bradley Sills
Bank of America Securities
Hold
Maintained
USD 304,00
+7,6%
03/04/2026
Last report
26 Aug. 2026
Fiscal period
Q2 2027
USD 2,35 / USD 2,22
+5,77%beat
Revenue / Est. (USD)
927,96 m / 905,26 m
+2,51%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Okt. 2025
Jan. 2026
Apr. 2026
Jul. 2026
Revenue
811,24 m
835,95 m
882,95 m
927,96 m
Cost of goods sold
199,46 m
213,48 m
220,92 m
232,01 m
Cost of revenue
199,46 m
213,48 m
220,92 m
232,01 m
Research and development expenses
191,88 m
198,79 m
208,32 m
222,92 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
179,04 m
177,80 m
180,59 m
198,02 m
Operating expense
370,92 m
376,60 m
388,91 m
420,93 m
Total operating expenses
570,38 m
590,08 m
609,84 m
652,94 m
Operating income
240,85 m
245,88 m
273,11 m
275,02 m
Other non operating income
-
934,00 k
-
-
EBT including unusual items
312,79 m
317,54 m
347,53 m
349,53 m
EBT excluding unusual items
312,79 m
315,70 m
345,74 m
349,53 m
Income tax expense
76,58 m
73,33 m
86,59 m
76,10 m
Effective tax rate
24,48%
23,09%
24,92%
21,77%
Other operating expenses
-
-
-
-
Net income
236,20 m
244,20 m
260,94 m
273,43 m
Net profit margin
29,12%
29,21%
29,55%
29,47%
Earnings per share
2,04
2,06
2,24
2,35
Interest and investment income
71,93 m
74,35 m
70,63 m
72,51 m
Interest expense
-
-
-
-
Net interest expenses
71,93 m
74,35 m
70,63 m
72,51 m
Depreciation and amortization charges
-
-
-
-
EBITDA
250,56 m
254,19 m
284,70 m
285,89 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme